メサンギウム サイボウ ゾウショク ニカンスル アラタナ セイギョ インシ ト ビョウヘン ヨクシ ニカンスル ケンキュウ

Mesangial proliferation is a common feature of many glomerular diseases, therefore, understanding the regulatory mechanism is important for the treatment of glomerular diseases. The present study showed growth arrest gene-6 (Gas6) is a new autocrine growth factor of mesangial cells and warfarin inhibited mesangial proliferation by inhibiting γ-carboxylation of Gas 6 in vitro and in vivo. We also found vitamin D anlog (22-oxa-calcitriol) is a new growth regulator for mesangial cells in vivo. These results indicate that these compounds have considerable potential for use as therapeutic strategy in the treatment of progressive glomerular disease

The contribution of mesangial cell proliferation to progressive glomerular injury

Mesangial cell proliferation is a general characteristic of a variety of glomerular diseases. Therefore, an understanding of the regulatory mechanism is important for treatment of glomerular diseases. The present review shows that the growth arrest gene 6 (Gas 6) is a new autocrine growth factor of mesangial cells and that warfarin inhibits mesangial cell proliferation by inhibiting the γ-carboxylation of Gas 6 in vitro and in vivo. The present findings also show that a vitamin D analog (22-oxa-calcitriol) is a new growth regulator of mesangial cells in vitro and in vivo. These findings indicate that these compounds have considerable potential for therapeutic use in the treatment of progressive glomerular disease

The determination of glial fibrillary acidic protein for the diagnosis and histogenetic study of central nervous system tumors: a study of 152 cases.

Glial fibrillary acidic protein (GFAP) was purified from human spinal cord and cerebral white matter. GFAP was localized by an immuno-peroxidase method in normal adult and fetal human brains, rat brains, and 152 central nervous system (CNS) tumors. GFAP was found in reactive and normal astrocytes, immature cells of fetal brain at the 18th to 21st gestational weeks, and normal rat astrocytes. This GFAP staining was quite specific for glial tumors, including astrocytomas, glioblastomas, astroblastomas, and ependymomas. GFAP-positive cells were also found in oligodendrogliomas and choroid plexus papillomas, and they were interpreted as being astroglial or ependymal differentiations. Stromal cells in cerebellar hemangioblastomas were negative. However, engulfed astrocytes were found at the periphery of such tumors and often adjacent to the proliferate blood vessels. In meningiomas, neurinomas, metastatic carcinomas, pituitary adenomas and other non-glial tumors, GFAP-positive cells were not identified.</p

Low serum sodium concentration is a prognostic factor related to current blood glucose level in stable hemodialysis patients : an observational study

Background: A lot of risk factors for mortality have been proposed in hemodialysis patients. However, most of the findings were derived from the analyses using all of the hemodialysis patients. What we really want to know is the prognostic factor in stable hemodialysis patients who have good activities of daily living, because it is difficult to estimate their prognosis by physical appearance. Methods: This is a 7-year observational study. The study involved registering 631 patients who had undergone hemodialysis for more than 1 year at enrollment and were still alive more than 1 year after it. Demographic and clinical data were collected to analyze the relationship with mortality. Moreover, the patients were age-stratified to investigate age-dependent prognostic factors. Results: Low serum sodium concentration is an independent risk factor for all-cause and cardiovascular mortality common to a wide range of ages in stable hemodialysis patients. Causes of hyponatremia included the predialysis blood glucose level as well as the variables related to nutrition, inflammation, and fluid overload. Conclusions: Low serum sodium concentration is a significant prognostic factor in stable hemodialysis patients. Low serum sodium concentration can be a clue to finding current poor glucose control in stable hemodialysis patients. Predialysis blood glucose level is one of the representative factors correlated with serum sodium concentration

Simultaneous Use of Both Bilateral Intralaminar and Pedicle Screws for C2 Stabilization

Four patients underwent stabilization surgery using both bilateral C2 pedicle screw (PS) and intralaminar screw (LS). Neural and vascular injury resulting from incorrect screw placement was assessed using computed tomography (CT). The evaluation of bone union was assessed by lateral flexion-extension X-ray films and CT. The symptoms were improved in all patients. There were no intraoperative complications. Furthermore, there were no cases of neurological worsening or vascular injury from incorrect screw placement. Failure of instrumentation or screw loosening during the follow-up period did not occur in any of the patients. All cases had accomplished bone union at the final follow-up. Theoretically, the stabilization technique using both bilateral C2 PS and LS at the same time can provide more stability than any other single technique. Simultaneous use of both bilateral C2 PS and LS is potentially a good choice for surgical repair